Oncocross is an Artificial Intelligence-based pharmaceutical company

specializing in drug discovery/cancer drug development.

We can find most adequate indication of specific drugs and best partner drugs.

ONCO AI platform allows patients to receive the best care and

precision medicine, and pharmaceutical companies to increase the success rate of

drug development at low cost and less time.

BUSINESS AREAS

  • Extended profile

    Find novel indication of drugs
    undergoing phase Ⅱ or Ⅲ study

  • Rescue drug

    Find novel indication of drugs
    that pass the phaseⅠclinical study
    but fail the phase Ⅱ or Ⅲ study

  • Intractable and Orphan drug

    In-house pipeline (sarcopenia drug,
    anti-metastasis drug, liver cirrhosis drug,
    irritable bowel syndrome drug, ALS, DMD)

  • Incrementally Modified
    Drug / IMD

    Make combination drug by screening
    best partner drugs which can induce
    synergic effect with previously used drugs

  • New Chemical Entity
    / NCE

    Find optimal indication of new
    chemical compounds of pharmaceutical
    company or research institute

  • New indication of
    Biologic drug

    Find optimal indication of new
    biologic drugs of pharmaceutical
    company or research institute

CONTACT US

If you have any questions, please don't hesitate to contact us.

+82-2-867-9967

  • ADDRESS : 15F, Gongdeok B/D, 11, Saechang-ro, Mapo-gu, Seoul 04168, Korea
  • FAX : +82-2-867-9968 IE-MAIL : oncocross@oncocross.com